Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
UBS voting stake in Renk drops to 4.57% from 5.36%

UBS voting stake in Renk drops to 4.57% from 5.36%

BitgetBitget2026/09/25 09:12
  • UBS cut its total voting rights stake in Renk to 4.57% from 5.36%, a disclosure dated Sept. 25.
  • The threshold was crossed on Sept. 23.
  • Voting rights attached to shares fell to 0.51% from 1.3%.
  • Voting rights through instruments held steady at 4.06%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Renk Group AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609250511OMX_____CNEWS_EN_GNW1001274559_en) on September 25, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.

智通财经•2026/11/15 04:01
From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

UNI falls below $5

金色财经•2026/11/15 03:37
UNI falls below $5